Automated lipid nanoparticle production could accelerate the development of RNA therapies

AI Summary

MIT researchers have developed a faster, more precisely controlled method for producing lipid nanoparticles used to package RNA vaccines and other nucleic acid therapies. The approach could accelerate development of these treatments by improving control over particle size and shape.

RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape.